Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HERPUD1, or Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein, is a stress-inducible integral membrane protein of the endoplasmic reticulum. It is a component of the ER quality control machinery and ER-associated protein degradation (ERAD), participating in the recognition and ubiquitin-dependent disposal of misfolded proteins. HERPUD1 contains a pivotal ubiquitin-like domain (UBL) at its N-terminus, crucial for its regulated proteasomal degradation. Its expression is upregulated under ER stress and by the unfolded protein response (UPR). HERPUD1 interacts with ubiquilin and presenilin family members, impacting amyloid-beta production. Stabilized HERPUD1 downregulates autophagy, promotes ER remodeling into stacked tubular forms, and establishes ER-lysosome contact sites, which favor cell survival under stress conditions. It is implicated in neurodegenerative diseases due to its influence on amyloid-beta and is associated with cancer cell survival and adaptation to cellular stress, making it a relevant therapeutic target in cancer and possibly other proteinopathy-related diseases.
Induction or inhibition of ER stress responses regulates HERPUD1 expression. Modulation of proteasomal degradation (i.e., proteasome inhibitors such as MG132 stabilize HERPUD1 levels). Possible modulation of autophagy, especially under stress or in cancer therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein (HERPUD1).